{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/fortrea-your-trusted-ally-navigate-complex-and-evolving-requirements-your-clinical-trial#webpage",
"url": "https://www.fortrea.com/insights/fortrea-your-trusted-ally-navigate-complex-and-evolving-requirements-your-clinical-trial",
"name": "Fortrea is your trusted ally to navigate the complex and evolving requirements for your Clinical Trial Signal Detection needs",
"description": "TThis Fortrea info sheet highlights how clinical trial signal detection was strengthened through proactive safety surveillance and integrated clinical safety management during ongoing clinical development activities. The study involved operational challenges related to adverse event monitoring, clinical safety data analysis, pharmacovigilance signal management, and maintaining regulatory safety compliance across evolving clinical trial environments. The case study highlights how proactive risk mitigation and proactive identification of safety signals required coordinated drug safety surveillance, structured signal review workflows, and continuous evaluation of emerging clinical safety data throughout the study lifecycle. Fortrea implemented integrated clinical safety management processes designed to support clinical trial signal detection, benefit-risk assessment in clinical trials, and ongoing pharmacovigilance oversight across operational and safety teams. By integrating adverse event monitoring with structured signal detection strategies, safety data analysis, and pharmacovigilance operations, the approach strengthened early identification of potential safety concerns and supported informed clinical safety decision-making throughout trial execution."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Fortrea is your trusted ally to navigate the complex and evolving requirements for your Clinical Trial Signal Detection needs",
"item": "https://www.fortrea.com/insights/fortrea-your-trusted-ally-navigate-complex-and-evolving-requirements-your-clinical-trial"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/fortrea-your-trusted-ally-navigate-complex-and-evolving-requirements-your-clinical-trial#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/fortrea-your-trusted-ally-navigate-complex-and-evolving-requirements-your-clinical-trial#webpage"
},
"headline": "Strengthening Clinical Trial Signal Detection Through Proactive Safety Monitoring |Fortrea Info Sheet",
"description": "This Fortrea info sheet highlights how clinical trial signal detection was strengthened through proactive safety surveillance and integrated clinical safety management during ongoing clinical development activities. The study involved operational challenges related to adverse event monitoring, clinical safety data analysis, pharmacovigilance signal management, and maintaining regulatory safety compliance across evolving clinical trial environments. The case study highlights how proactive risk mitigation and proactive identification of safety signals required coordinated drug safety surveillance, structured signal review workflows, and continuous evaluation of emerging clinical safety data throughout the study lifecycle. Fortrea implemented integrated clinical safety management processes designed to support clinical trial signal detection, benefit-risk assessment in clinical trials, and ongoing pharmacovigilance oversight across operational and safety teams. By integrating adverse event monitoring with structured signal detection strategies, safety data analysis, and pharmacovigilance operations, the approach strengthened early identification of potential safety concerns and supported informed clinical safety decision-making throughout trial execution.",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-12/fortrea-clinical-trial-signal-detection.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-12-11",
"dateModified": "2025-02-11",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-12/fortrea-clinical-trial-signal-detection.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/fortrea-your-trusted-ally-navigate-complex-and-evolving-requirements-your-clinical-trial#webpage",
"url": "https://www.fortrea.com/insights/fortrea-your-trusted-ally-navigate-complex-and-evolving-requirements-your-clinical-trial",
"name": "Fortrea is your trusted ally to navigate the complex and evolving requirements for your Clinical Trial Signal Detection needs",
"description": "TThis Fortrea info sheet highlights how clinical trial signal detection was strengthened through proactive safety surveillance and integrated clinical safety management during ongoing clinical development activities. The study involved operational challenges related to adverse event monitoring, clinical safety data analysis, pharmacovigilance signal management, and maintaining regulatory safety compliance across evolving clinical trial environments. The case study highlights how proactive risk mitigation and proactive identification of safety signals required coordinated drug safety surveillance, structured signal review workflows, and continuous evaluation of emerging clinical safety data throughout the study lifecycle. Fortrea implemented integrated clinical safety management processes designed to support clinical trial signal detection, benefit-risk assessment in clinical trials, and ongoing pharmacovigilance oversight across operational and safety teams. By integrating adverse event monitoring with structured signal detection strategies, safety data analysis, and pharmacovigilance operations, the approach strengthened early identification of potential safety concerns and supported informed clinical safety decision-making throughout trial execution."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Fortrea is your trusted ally to navigate the complex and evolving requirements for your Clinical Trial Signal Detection needs",
"item": "https://www.fortrea.com/insights/fortrea-your-trusted-ally-navigate-complex-and-evolving-requirements-your-clinical-trial"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/fortrea-your-trusted-ally-navigate-complex-and-evolving-requirements-your-clinical-trial#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/fortrea-your-trusted-ally-navigate-complex-and-evolving-requirements-your-clinical-trial#webpage"
},
"headline": "Strengthening Clinical Trial Signal Detection Through Proactive Safety Monitoring |Fortrea Info Sheet",
"description": "This Fortrea info sheet highlights how clinical trial signal detection was strengthened through proactive safety surveillance and integrated clinical safety management during ongoing clinical development activities. The study involved operational challenges related to adverse event monitoring, clinical safety data analysis, pharmacovigilance signal management, and maintaining regulatory safety compliance across evolving clinical trial environments. The case study highlights how proactive risk mitigation and proactive identification of safety signals required coordinated drug safety surveillance, structured signal review workflows, and continuous evaluation of emerging clinical safety data throughout the study lifecycle. Fortrea implemented integrated clinical safety management processes designed to support clinical trial signal detection, benefit-risk assessment in clinical trials, and ongoing pharmacovigilance oversight across operational and safety teams. By integrating adverse event monitoring with structured signal detection strategies, safety data analysis, and pharmacovigilance operations, the approach strengthened early identification of potential safety concerns and supported informed clinical safety decision-making throughout trial execution.",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-12/fortrea-clinical-trial-signal-detection.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-12-11",
"dateModified": "2025-02-11",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-12/fortrea-clinical-trial-signal-detection.pdf",
"encodingFormat": "application/pdf"
}
}
]
}
Info Sheet
Fortrea is your trusted ally to navigate the complex and evolving requirements for your Clinical Trial Signal Detection needs
Clinical Trial Signal Detection (CTSD) is a systematic process of identifying potential safety signals or emerging safety concerns associated with investigational medicines. Given the constantly changing dynamics in benefit-risk assessments, there is an increasing concern about the poorly defined safety profiles of investigational medicinal products (IMPs). Regulatory requirements mandate monitoring patient safety during clinical trials, which necessitates an effective clinical trial signal detection process.